Singapore markets close in 1 hour 23 minutes

PAVmed Inc. (PAVMW)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.0290+0.0149 (+105.67%)
At close: 12:36PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.0141
Open1.3700
Bid1.2300 x 1000
Ask1.4000 x 1100
Day's range0.0200 - 0.0290
52-week range0.0200 - 4.7430
Volume32,626
Avg. volume6,563
Market cap769,747
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split

    PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors today announced a dividend of approximately 3.3 million shares of common stock of its majority-owned subsidiary, Lucid Diagnostics Inc. (Nasdaq: LUCD), which equals the number of shares PAVmed will receive in the contemporaneous partial settlement of outstanding intercompany debt owed to PAVmed by Lucid.

  • Insider Monkey

    PAVmed Inc. (NASDAQ:PAVM) Q3 2023 Earnings Call Transcript

    PAVmed Inc. (NASDAQ:PAVM) Q3 2023 Earnings Call Transcript November 15, 2023 Operator: Good day, and welcome to the PAVmed Third Quarter 2023 Business Update Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s remarks, there will be an opportunity to ask questions. [Operator Instructions] Please also note that today’s event […]

  • Insider Monkey

    Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript

    Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good morning, and welcome to the Lucid Diagnostics Third Quarter 2023 Business Update Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note that this event is being recorded. I would now like to turn the conference over […]